- February 23, 2012
- 06:33 AM CET
- search
- T&C's
- Disclaimer
- PRIVACY POLICY
- Imprint
- RSS
- ©2012 EVOTEC
- Loading...
Selected drug discovery alliances
| Partner | Focus area | Description |
| Boehringer Ingelheim | Oncology,pain inflammation | Performance-based, multi-target long-term alliance. Significant milestones and royalties |
| Boehringer Ingelheim | Metabolics, insulin sensitizer |
Diabetes, obesity and metabolic syndrome Research funding, €7m upfront, >€230m milestones, royalties |
| CHDI | CNS, Huntington disease | Long-term alliance, focused on the fight against Huntington disease |
| Cubist | Various | Multi-target long term alliances |
| Genentech | CNS, pain,others | Long-term alliance, focused on multiple targets |
| Medimmune/AstraZeneca | BetaCell technology (biologicals) | Type 1 and 2 diabetes, targeting beta cell mass. Research funding, €5m upfront, >€250m milestones, royalties |
| Novartis | CNS, pain | Performance-based, multi-target long-term alliance. Significant milestones and royalties |
| Ono | Various | Performance-based, multi-target long-term alliance. Significant milestones and royalties |
| Roche |
Response prediction |
Performance-based alliance, focused on development of response predicting biomarkers |
| Shionogi | Various | Multi-target long term alliances |
| UCB | CNS | Performance-based, long-term alliance, focused on CNS targets |
| Vifor | Anemia | Performance-based alliance, focused on anemia targets |
Drug discovery alliances
Boehringer Ingelheim: Insulin Sensitizer
An integrated discovery alliance with Boehringer Ingelheim was signed
- read moreBoehringer Ingelheim
Evotec and Boehringer Ingelheim enter into multi-year, multi target collaboration
- read moreBiogen Idec
Evotec announces Research Agreement with Biogen Idec focusing on hit identification
- read moreCHDI
CHDI selects Evotec as strategic drug discovery partner in the search for Huntington's disease treatments
- read moreCubist
Research agreement on fragment-based drug discovery
- read moreGenentech
Integrated Drug Discovery Alliance with Genentech
- read moreMedImmune/AstraZeneca: EVT 770
License and collaboration agreement with MedImmune (the global biologics unit of AstraZeneca), to develop EVT 770
- read moreNovartis
Three year drug discovery collaboration to identify and develop novel small molecule therapeutics
- read moreOno
Extension of research collaboration with Ono to include an ion channel target
- read moreRoche
Evotec and Roche to jointly develop biomarkers in oncology - an alliance for personalized healthcare in cancer research and development
- read moreVifor
Major Cooperation Agreement in the field of anaemia
- read more